Journal Information

Statistics

Follow this link to access the full text of the article

Short Original
Tocilizumab in the treatment of active chronic humoral rejection resistant to standard therapy
Tocilizumab en el tratamiento del rechazo humoral crónico activo resistente a terapia estándar
Betty Chamouna,
Corresponding author
md.chamounbetty@gmail.com

Corresponding authors.
, Pablo Sánchez-Sanchob, Irina B. Torresa,
Corresponding author
ibtorres@vhebron.net

Corresponding authors.
, Alejandra Gabaldonc, Manel Perellóa, Joana Sellarésa, Francesc Moresoa, Daniel Seróna
a Servicio de Nefrología, Hospital Universitari Vall d’Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain
b Servicio de Farmacia, Hospital Universitari Vall d’Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain
c Servicio de Patología, Hospital Universitari Vall d’Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain
Read
3595
Times
was read the article
1419
Total PDF
2176
Total HTML
Share statistics
Article information
ISSN: 20132514
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 6 34 53 87
2025 5 152 42 194
2025 4 91 26 117
2025 3 140 64 204
2025 2 118 47 165
2025 1 81 48 129
2024 12 74 43 117
2024 11 70 56 126
2024 10 73 45 118
2024 9 71 36 107
2024 8 79 78 157
2024 7 68 32 100
2024 6 70 47 117
2024 5 58 44 102
2024 4 77 43 120
2024 3 56 33 89
2024 2 45 43 88
2024 1 61 31 92
2023 12 46 35 81
2023 11 68 34 102
2023 10 73 54 127
2023 9 53 37 90
2023 8 82 42 124
2023 7 77 68 145
2023 6 92 81 173
2023 5 86 72 158
2023 4 54 60 114
2023 3 70 56 126
2023 2 54 66 120
2023 1 3 3 6
Show all

Follow this link to access the full text of the article

Idiomas
Nefrología (English Edition)